Depression Treatment and Management: A Multimodal Approach

Major Depressive Disorder (MDD) has no single "cure" but is highly treatable. Most achieve remission or significant symptom reduction with appropriate care.

Evidence-Based Modalities

• Psychotherapy: CBT (cognitive restructuring, behavioral activation), IPT (interpersonal), BA, MBCT, psychodynamic – first-line for mild-moderate
• Pharmacotherapy: SSRIs (first-line), SNRIs, atypical (bupropion, mirtazapine), TCAs/MAOIs (refractory). 4–8 weeks for full effect.
• Combination: Therapy + medication > either alone for moderate-severe
• Neuromodulation: TMS (FDA-cleared for TRD), ECT (gold standard for severe/psychotic/catatonic), VNS, DBS (investigational)
• Lifestyle: Exercise (aerobic 150 min/wk), sleep hygiene, Mediterranean diet, alcohol reduction, social connection
• Adjunctive: Light therapy (seasonal), omega-3, folate (L-methylfolate), vitamin D if deficient

Treatment Algorithm

1. Assess severity, suicidality, comorbidities, preference
2. Mild: CBT or watchful waiting
3. Moderate: CBT + consider SSRI
4. Severe: SSRI + CBT; consider ECT if psychotic/catatonic/high suicide risk
5. Monitor: PHQ-9 q2–4 weeks; adjust at 4–6 weeks if <25% improvement
6. Maintenance: Continue 6–12 months after remission; longer if recurrent

Treatment-Resistant Depression (TRD)

Failure of ≥2 adequate antidepressant trials. Options: Switch, augment (atypical antipsychotic, lithium, thyroid), TMS, ECT, ketamine/esketamine, clinical trials.

Recovery is possible. Ongoing management prevents relapse. Therapeutic alliance is key.